Literature DB >> 8742474

A mutation in Alzheimer's disease destroying a splice acceptor site in the presenilin-1 gene.

J Perez-Tur1, S Froelich, G Prihar, R Crook, M Baker, K Duff, M Wragg, F Busfield, C Lendon, R F Clark.   

Abstract

A series of mutations has been reported in the presenilin-1 (PS-1) gene which cause early onset Alzheimer's disease (AD). The mutations reported to date have encoded missense mutations which alter residues conserved between PS-1 and the presenilin-2 (PS-2) gene. We have recently determined the intron/exon structure of the PS-1 gene and this information has been used to identify a mutation in the splice acceptor site for exon 9 in a family with early onset AD. Amplification of cDNA from lymphoblasts of affected individuals revealed that the effect of the mutation was to cause splicing out of exon 9, however it does not change the open reading frame of the mRNA. The importance of this observation is discussed.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 8742474

Source DB:  PubMed          Journal:  Neuroreport        ISSN: 0959-4965            Impact factor:   1.837


  47 in total

Review 1.  Presenilins: structural aspects and posttranslational events.

Authors:  F Checler
Journal:  Mol Neurobiol       Date:  1999-06       Impact factor: 5.590

2.  Correct heteroduplex formation for mutation detection analysis.

Authors:  M J Smith; K E Humphrey; R Cappai; K Beyreuther; C L Masters; R G Cotton
Journal:  Mol Diagn       Date:  2000-03

Review 3.  Genetic risk factors in Alzheimer's disease.

Authors:  L Tilley; K Morgan; N Kalsheker
Journal:  Mol Pathol       Date:  1998-12

Review 4.  Genetics, transcriptomics, and proteomics of Alzheimer's disease.

Authors:  Andreas Papassotiropoulos; Michael Fountoulakis; Travis Dunckley; Dietrich A Stephan; Eric M Reiman
Journal:  J Clin Psychiatry       Date:  2006-04       Impact factor: 4.384

5.  The presenilin loop region is essential for glycogen synthase kinase 3 β (GSK3β) mediated functions on motor proteins during axonal transport.

Authors:  Rupkatha Banerjee; Zoe Rudloff; Crystal Naylor; Michael C Yu; Shermali Gunawardena
Journal:  Hum Mol Genet       Date:  2018-09-01       Impact factor: 6.150

6.  N-carbamylglutamate enhancement of ureagenesis leads to discovery of a novel deleterious mutation in a newly defined enhancer of the NAGS gene and to effective therapy.

Authors:  Sandra K Heibel; Nicholas Ah Mew; Ljubica Caldovic; Yevgeny Daikhin; Marc Yudkoff; Mendel Tuchman
Journal:  Hum Mutat       Date:  2011-09-09       Impact factor: 4.878

7.  Functional and topological analysis of Pen-2, the fourth subunit of the gamma-secretase complex.

Authors:  Leen Bammens; Lucía Chávez-Gutiérrez; Alexandra Tolia; An Zwijsen; Bart De Strooper
Journal:  J Biol Chem       Date:  2011-02-04       Impact factor: 5.157

Review 8.  The Alzheimer family of diseases: many etiologies, one pathogenesis?

Authors:  J Hardy
Journal:  Proc Natl Acad Sci U S A       Date:  1997-03-18       Impact factor: 11.205

Review 9.  Dynamic Nature of presenilin1/γ-Secretase: Implication for Alzheimer's Disease Pathogenesis.

Authors:  Katarzyna Marta Zoltowska; Oksana Berezovska
Journal:  Mol Neurobiol       Date:  2017-03-22       Impact factor: 5.590

10.  De novo presenilin 1 mutations are rare in clinically sporadic, early onset Alzheimer's disease cases. French Alzheimer's Disease Study Group.

Authors:  C Dumanchin; A Brice; D Campion; D Hannequin; C Martin; V Moreau; Y Agid; M Martinez; F Clerget-Darpoux; T Frebourg
Journal:  J Med Genet       Date:  1998-08       Impact factor: 6.318

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.